Oral azacitidine maintenance therapy for patients with acute myeloid leukaemia and myelodysplasia-related changes: Post hoc analysis of the QUAZAR AML-001 trial. Academic Article uri icon

Overview

publication date

  • December 12, 2025

Identity

Scopus Document Identifier

  • 105024611700

Digital Object Identifier (DOI)

  • 10.1111/bjh.70272

PubMed ID

  • 41387169

Additional Document Info

volume

  • 208

issue

  • 2